Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial).

Further post-hoc analysis identified that an additional 12% of residents in the intervention arm avoided cognitive decline of two or more points at 12 months, although this did not reach statistical significance ( Supplement 5 , Table S3 , Supplementary data are available in Age and Ageing online).

also in 111,027 other papers